| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.928 | 0.001 | 0.928 | Alpha-N-acetylglucosaminidase inhibitor | 0.876 0.001 DBMET00509 | ||
| 0.861 | 0.002 | 0.861 | Alcohol oxidase inhibitor | |||
| 0.807 | 0.004 | 0.828 | Hypoglycemic | 0.828 0.004 DBMET00509 | DBMET00509 | |
| 0.798 | 0.004 | 0.798 | Aldehyde oxidase inhibitor | |||
| 0.798 | 0.007 | 0.932 | Cyclophilin D inhibitor | 0.932 0.004 DBMET00509 | DBMET00509 | |
| 0.771 | 0 | 0.771 | Mannitol 2-dehydrogenase inhibitor | |||
| 0.696 | 0.001 | 0.696 | Triose-phosphate isomerase inhibitor | 0.532 0.002 DBMET00509 | ||
| 0.662 | 0.003 | 0.662 | Chelator | 0.104 0.071 DBMET00509 | ||
| 0.639 | 0.004 | 0.639 | Interleukin 6 antagonist | 0.483 0.005 DBMET00509 | ||
| 0.633 | 0.007 | 0.633 | 5 Hydroxytryptamine release inhibitor | 0.301 0.163 DBMET00509 | ||
| 0.631 | 0.009 | 0.706 | Immunosuppressant | 0.706 0.005 DBMET00509 | DBMET00509 | |
| 0.62 | 0.004 | 0.844 | Amylase inhibitor | 0.844 0.001 DBMET00509 | DBMET00509 | |
| 0.609 | 0.004 | 0.609 | Peroxidase inhibitor | |||
| 0.609 | 0.006 | 0.609 | Hypolipemic | 0.414 0.023 DBMET00509 | ||
| 0.598 | 0.019 | 0.854 | Cholesterol antagonist | 0.854 0.003 DBMET00509 | DBMET00509 | |
| 0.581 | 0.002 | 0.762 | NADH dehydrogenase inhibitor | 0.762 0.001 DBMET00509 | DBMET00509 | |
| 0.581 | 0.004 | 0.581 | Hematopoietic | |||
| 0.586 | 0.016 | 0.763 | 5 Hydroxytryptamine release stimulant | 0.763 0.004 DBMET00509 | DBMET00509 | |
| 0.583 | 0.013 | 0.844 | Immunomodulator | 0.844 0.004 DBMET00509 | DBMET00509 | |
| 0.6 | 0.036 | 0.914 | Caspase 9 stimulant | 0.914 0.003 DBMET00509 | DBMET00509 | |
| 0.554 | 0.016 | 0.554 | Histamine release inhibitor | 0.424 0.063 DBMET00509 | ||
| 0.528 | 0.002 | 0.576 | UDP-glucose 4-epimerase inhibitor | 0.576 0.001 DBMET00509 | DBMET00509 | |
| 0.531 | 0.023 | 0.604 | Vasodilator, peripheral | 0.604 0.015 DBMET00509 | DBMET00509 | |
| 0.512 | 0.014 | 0.668 | Vasodilator, coronary | 0.668 0.005 DBMET00509 | DBMET00509 | |
| 0.496 | 0.014 | 0.748 | DNA synthesis inhibitor | 0.748 0.004 DBMET00509 | DBMET00509 | |
| 0.488 | 0.008 | 0.803 | Hepatoprotectant | 0.803 0.003 DBMET00509 | DBMET00509 | |
| 0.468 | 0.003 | 0.468 | Phenylalanine 4-hydroxylase inhibitor | |||
| 0.468 | 0.002 | 0.494 | Phosphofructokinase-1 inhibitor | 0.494 0.002 DBMET00509 | DBMET00509 | |
| 0.442 | 0.017 | 0.477 | Vasodilator | 0.477 0.014 DBMET00509 | DBMET00509 | |
| 0.506 | 0.085 | 0.934 | Antiinflammatory | 0.934 0.005 DBMET00509 | DBMET00509 | |
| 0.412 | 0.003 | 0.412 | Carbamoyl phosphate synthetase inhibitor | 0.139 0.013 DBMET00509 | ||
| 0.443 | 0.038 | 0.723 | Immunostimulant | 0.723 0.007 DBMET00509 | DBMET00509 | |
| 0.43 | 0.027 | 0.43 | Interleukin antagonist | 0.157 0.113 DBMET00509 | ||
| 0.446 | 0.043 | 0.446 | GABA C receptor rho-3 antagonist | |||
| 0.403 | 0.002 | 0.403 | Plasmepsin I inhibitor | |||
| 0.403 | 0.004 | 0.403 | Succinate dehydrogenase inhibitor | |||
| 0.4 | 0.004 | 0.4 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.334 0.005 DBMET00509 | ||
| 0.397 | 0.002 | 0.397 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.326 0.003 DBMET00509 | ||
| 0.423 | 0.031 | 0.913 | Antioxidant | 0.913 0.003 DBMET00509 | DBMET00509 | |
| 0.39 | 0.003 | 0.39 | Mannose-6-phosphate isomerase inhibitor | 0.351 0.004 DBMET00509 | ||
| 0.391 | 0.005 | 0.391 | Growth factor agonist | 0.163 0.115 DBMET00509 | ||
| 0.397 | 0.013 | 0.397 | Diuretic | 0.149 0.078 DBMET00509 | ||
| 0.395 | 0.028 | 0.395 | Superoxide dismutase inhibitor | |||
| 0.43 | 0.064 | 0.747 | Antibacterial | 0.747 0.006 DBMET00509 | DBMET00509 | |
| 0.368 | 0.005 | 0.464 | Expectorant | 0.464 0.004 DBMET00509 | DBMET00509 | |
| 0.36 | 0.002 | 0.802 | Alpha-mannosidase inhibitor | 0.802 0.001 DBMET00509 | DBMET00509 | |
| 0.357 | 0.003 | 0.357 | Biliverdin reductase inhibitor | 0.077 0.028 DBMET00509 | ||
| 0.36 | 0.006 | 0.36 | GABA C receptor agonist | |||
| 0.351 | 0.006 | 0.501 | Hexokinase inhibitor | 0.501 0.003 DBMET00509 | DBMET00509 | |
| 0.339 | 0.002 | 0.807 | Mannosidase inhibitor | 0.807 0.001 DBMET00509 | DBMET00509 | |
| 0.339 | 0.003 | 0.339 | Neuraminidase (influenza) inhibitor | 0.197 0.005 DBMET00509 | ||
| 0.34 | 0.004 | 0.34 | Mucolytic | 0.288 0.005 DBMET00509 | ||
| 0.334 | 0.005 | 0.334 | Adenylate kinase inhibitor | 0.168 0.021 DBMET00509 | ||
| 0.342 | 0.014 | 0.488 | Peptidyltransferase inhibitor | 0.488 0.004 DBMET00509 | DBMET00509 | |
| 0.337 | 0.01 | 0.608 | Alkylator | 0.608 0.004 DBMET00509 | DBMET00509 | |
| 0.347 | 0.024 | 0.663 | Anesthetic general | 0.663 0.004 DBMET00509 | DBMET00509 | |
| 0.331 | 0.009 | 0.331 | Aldehyde dehydrogenase inhibitor | 0.268 0.015 DBMET00509 | ||
| 0.33 | 0.01 | 0.352 | Insulin secretagoues | 0.352 0.008 DBMET00509 | DBMET00509 | |
| 0.32 | 0.001 | 0.345 | Glucose-6-phosphate isomerase inhibitor | 0.345 0.001 DBMET00509 | DBMET00509 | |
| 0.41 | 0.092 | 0.41 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.324 | 0.008 | 0.324 | Interleukin 1b antagonist | |||
| 0.348 | 0.041 | 0.348 | Sodium/bile acid cotransporter inhibitor | |||
| 0.336 | 0.033 | 0.876 | Interleukin agonist | 0.876 0.002 DBMET00509 | DBMET00509 | |
| 0.349 | 0.046 | 0.659 | Interleukin 2 agonist | 0.659 0.003 DBMET00509 | DBMET00509 | |
| 0.301 | 0.003 | 0.301 | Neuraminidase inhibitor | 0.135 0.008 DBMET00509 | ||
| 0.316 | 0.026 | 0.316 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.301 | 0.011 | 0.312 | Nitric-oxide synthase stimulant | 0.312 0.009 DBMET00509 | DBMET00509 | |
| 0.348 | 0.065 | 0.854 | Antithrombotic | 0.854 0.003 DBMET00509 | DBMET00509 | |
| 0.288 | 0.009 | 0.288 | Ferrochelatase inhibitor | |||
| 0.281 | 0.004 | 0.281 | Sphingomyelinase inhibitor | 0.246 0.005 DBMET00509 | ||
| 0.283 | 0.006 | 0.799 | Selectin antagonist | 0.799 0.001 DBMET00509 | DBMET00509 | |
| 0.289 | 0.017 | 0.633 | Hemostatic | 0.633 0.003 DBMET00509 | DBMET00509 | |
| 0.308 | 0.039 | 0.308 | Cyclic AMP phosphodiesterase inhibitor | 0.23 0.074 DBMET00509 | ||
| 0.33 | 0.064 | 0.33 | Calcium channel activator | |||
| 0.296 | 0.032 | 0.56 | RNA-directed DNA polymerase inhibitor | 0.56 0.007 DBMET00509 | DBMET00509 | |
| 0.283 | 0.02 | 0.283 | Phospholipase C inhibitor | 0.179 0.062 DBMET00509 | ||
| 0.272 | 0.012 | 0.272 | MAP kinase kinase inhibitor | |||
| 0.38 | 0.123 | 0.822 | Alpha-glucosidase inhibitor | 0.822 0.016 DBMET00509 | DBMET00509 | |
| 0.267 | 0.013 | 0.443 | Cell wall synthesis inhibitor | 0.443 0.005 DBMET00509 | DBMET00509 | |
| 0.292 | 0.038 | 0.292 | Gastrin inhibitor | 0.28 0.049 DBMET00509 | ||
| 0.255 | 0.007 | 0.255 | Glutamate dehydrogenase inhibitor | 0.092 0.035 DBMET00509 | ||
| 0.257 | 0.008 | 0.257 | Catalase inhibitor | |||
| 0.295 | 0.048 | 0.295 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.253 | 0.008 | 0.253 | Microtubule formation inhibitor | 0.19 0.022 DBMET00509 | ||
| 0.247 | 0.004 | 0.247 | Glutamate decarboxylase inhibitor | |||
| 0.283 | 0.041 | 0.283 | MAP kinase kinase 2 inhibitor | |||
| 0.254 | 0.018 | 0.254 | Interleukin 1 antagonist | |||
| 0.244 | 0.009 | 0.244 | Histidine decarboxylase inhibitor | |||
| 0.241 | 0.007 | 0.241 | GABA C receptor antagonist | |||
| 0.237 | 0.005 | 0.237 | Keratolytic | |||
| 0.231 | 0.004 | 0.231 | Acyl-CoA dehydrogenase inhibitor | 0.076 0.024 DBMET00509 | ||
| 0.231 | 0.005 | 0.231 | Adenylate cyclase stimulant | 0.191 0.018 DBMET00509 | ||
| 0.249 | 0.027 | 0.501 | Protein kinase stimulant | 0.501 0.004 DBMET00509 | DBMET00509 | |
| 0.259 | 0.039 | 0.282 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.282 0.029 DBMET00509 | DBMET00509 | |
| 0.231 | 0.011 | 0.231 | MAP kinase kinase 5 inhibitor | |||
| 0.227 | 0.007 | 0.227 | Creatine kinase inhibitor | |||
| 0.229 | 0.012 | 0.229 | Arachidonic acid antagonist | |||
| 0.219 | 0.004 | 0.219 | HIV-1 protease inhibitor | |||
| 0.288 | 0.075 | 0.494 | Spasmolytic | 0.494 0.024 DBMET00509 | DBMET00509 | |
| 0.215 | 0.004 | 0.215 | Maillard reaction inhibitor | |||
| 0.212 | 0.003 | 0.212 | Aconitate hydratase inhibitor | |||
| 0.314 | 0.107 | 0.371 | Antiobesity | 0.371 0.077 DBMET00509 | DBMET00509 | |
| 0.247 | 0.04 | 0.328 | Neurotrophic factor enhancer | 0.328 0.012 DBMET00509 | DBMET00509 | |
| 0.207 | 0.005 | 0.363 | Interferon agonist | 0.363 0.002 DBMET00509 | DBMET00509 | |
| 0.208 | 0.007 | 0.208 | GABA C receptor rho-1 antagonist | |||
| 0.218 | 0.017 | 0.218 | Aminopeptidase B inhibitor | |||
| 0.241 | 0.04 | 0.241 | Insulin sensitizer | 0.192 0.082 DBMET00509 | ||
| 0.244 | 0.043 | 0.244 | P-glycoprotein inhibitor | 0.155 0.11 DBMET00509 | ||
| 0.231 | 0.032 | 0.471 | Interferon gamma antagonist | 0.471 0.007 DBMET00509 | DBMET00509 | |
| 0.267 | 0.071 | 0.769 | DNA damaging | 0.769 0.004 DBMET00509 | DBMET00509 | |
| 0.2 | 0.007 | 0.2 | Aminopeptidase I inhibitor | |||
| 0.263 | 0.073 | 0.278 | Cardiotonic | 0.278 0.066 DBMET00509 | DBMET00509 | |
| 0.223 | 0.034 | 0.478 | Melanin inhibitor | 0.478 0.008 DBMET00509 | DBMET00509 | |
| 0.269 | 0.08 | 0.269 | Insulysin inhibitor | |||
| 0.192 | 0.004 | 0.192 | Ca2+-transporting ATPase inhibitor | 0.187 0.005 DBMET00509 | ||
| 0.201 | 0.014 | 0.545 | Mediator release inhibitor | 0.545 0.004 DBMET00509 | DBMET00509 | |
| 0.211 | 0.024 | 0.211 | Cholesterol synthesis inhibitor | 0.099 0.089 DBMET00509 | ||
| 0.206 | 0.021 | 0.206 | Toll-Like receptor 2 antagonist | 0.173 0.038 DBMET00509 | ||
| 0.191 | 0.007 | 0.191 | Ornithine carbamoyltransferase inhibitor | 0.05 0.04 DBMET00509 | ||
| 0.186 | 0.006 | 0.186 | MAP kinase kinase 1 inhibitor | |||
| 0.199 | 0.021 | 0.474 | Antineoplastic antibiotic | 0.474 0.004 DBMET00509 | DBMET00509 | |
| 0.207 | 0.032 | 0.235 | ATPase inhibitor | 0.235 0.018 DBMET00509 | DBMET00509 | |
| 0.262 | 0.09 | 0.262 | Hypoxia-inducible factor 1 alpha inhibitor | 0.237 0.112 DBMET00509 | ||
| 0.185 | 0.014 | 0.191 | Alcohol dehydrogenase inhibitor | 0.191 0.013 DBMET00509 | DBMET00509 | |
| 0.176 | 0.006 | 0.283 | Phosphorylase inhibitor | 0.283 0.004 DBMET00509 | DBMET00509 | |
| 0.171 | 0.002 | 0.171 | Neuraminidase (Influenza A) inhibitor | 0.042 0.039 DBMET00509 | ||
| 0.177 | 0.012 | 0.177 | Electrolyte absorption antagonist | |||
| 0.169 | 0.004 | 0.169 | Glucosylceramidase inhibitor | 0.121 0.005 DBMET00509 | ||
| 0.183 | 0.018 | 0.183 | Protease inhibitor | |||
| 0.232 | 0.067 | 0.232 | Pyruvate kinase inhibitor | |||
| 0.21 | 0.047 | 0.21 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.183 | 0.021 | 0.183 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.197 | 0.035 | 0.197 | Cyclin-dependent kinase 3 inhibitor | |||
| 0.181 | 0.024 | 0.181 | MAP kinase kinase 4 inhibitor | |||
| 0.184 | 0.028 | 0.184 | Cystathionine beta-synthase inhibitor | 0.101 0.076 DBMET00509 | ||
| 0.172 | 0.016 | 0.172 | Porphobilinogen synthase inhibitor | |||
| 0.171 | 0.019 | 0.171 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.185 | 0.033 | 0.272 | DNA polymerase I inhibitor | 0.272 0.014 DBMET00509 | DBMET00509 | |
| 0.156 | 0.004 | 0.156 | Sphingosine 1-phosphate receptor 3 agonist | |||
| 0.188 | 0.036 | 0.188 | GABA C receptor rho-2 antagonist | |||
| 0.229 | 0.08 | 0.894 | Angiogenesis stimulant | 0.894 0.002 DBMET00509 | DBMET00509 | |
| 0.208 | 0.065 | 0.208 | DNA methyltransferase I inhibitor | 0.189 0.075 DBMET00509 | ||
| 0.156 | 0.017 | 0.156 | NAD(P)H dehydrogenase (quinone) inhibitor | |||
| 0.141 | 0.004 | 0.141 | Fumarate hydratase inhibitor | 0.042 0.017 DBMET00509 | ||
| 0.199 | 0.067 | 0.806 | Nitric oxide antagonist | 0.806 0.004 DBMET00509 | DBMET00509 | |
| 0.166 | 0.035 | 0.306 | Antibacterial (Helicobacter pylori) | 0.306 0.006 DBMET00509 | DBMET00509 | |
| 0.14 | 0.01 | 0.14 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.135 | 0.006 | 0.135 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.15 | 0.021 | 0.15 | DOPA decarboxylase inhibitor | |||
| 0.164 | 0.037 | 0.335 | Cyclooxygenase 3 inhibitor | 0.335 0.005 DBMET00509 | DBMET00509 | |
| 0.138 | 0.012 | 0.314 | Histone deacetylase stimulant | 0.314 0.004 DBMET00509 | DBMET00509 | |
| 0.138 | 0.012 | 0.314 | Histone deacetylase SIRT1 stimulant | 0.314 0.004 DBMET00509 | DBMET00509 | |
| 0.203 | 0.077 | 0.275 | DNA methylase inhibitor | 0.275 0.036 DBMET00509 | DBMET00509 | |
| 0.187 | 0.062 | 0.187 | Tumour necrosis factor antagonist | |||
| 0.135 | 0.012 | 0.135 | Toll-Like receptor 2 agonist | 0.098 0.015 DBMET00509 | ||
| 0.156 | 0.033 | 0.156 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.126 | 0.004 | 0.126 | Epithelial sodium channel blocker | |||
| 0.143 | 0.022 | 0.143 | Anabolic | |||
| 0.16 | 0.039 | 0.269 | Adenylate cyclase inhibitor | 0.269 0.017 DBMET00509 | DBMET00509 | |
| 0.13 | 0.01 | 0.13 | Glycine receptor agonist | 0.106 0.018 DBMET00509 | ||
| 0.128 | 0.011 | 0.128 | Cathepsin D inhibitor | |||
| 0.142 | 0.025 | 0.142 | Calcium antagonist | |||
| 0.131 | 0.016 | 0.344 | Glutamate release inhibitor | 0.344 0.003 DBMET00509 | DBMET00509 | |
| 0.16 | 0.045 | 0.16 | Anesthetic local | |||
| 0.128 | 0.014 | 0.128 | Argininosuccinate synthase inhibitor | 0.071 0.029 DBMET00509 | ||
| 0.138 | 0.026 | 0.138 | Androgen antagonist | |||
| 0.155 | 0.043 | 0.155 | Cathepsin H inhibitor | |||
| 0.119 | 0.008 | 0.119 | GABA B receptor agonist | |||
| 0.116 | 0.005 | 0.116 | Sphingosine kinase inhibitor | |||
| 0.129 | 0.018 | 0.306 | Phosphodiesterase 6D inhibitor | 0.306 0.003 DBMET00509 | DBMET00509 | |
| 0.131 | 0.021 | 0.131 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.113 | 0.005 | 0.113 | Prostaglandin agonist | |||
| 0.189 | 0.08 | 0.471 | Non-steroidal antiinflammatory agent | 0.471 0.008 DBMET00509 | DBMET00509 | |
| 0.148 | 0.041 | 0.202 | Vanilloid 1 agonist | 0.202 0.011 DBMET00509 | DBMET00509 | |
| 0.116 | 0.012 | 0.116 | Estrogen-related receptor beta agonist | |||
| 0.134 | 0.03 | 0.134 | Prolactin inhibitor | |||
| 0.11 | 0.006 | 0.11 | Phosphoglycerate kinase inhibitor | 0.051 0.013 DBMET00509 | ||
| 0.108 | 0.005 | 0.108 | Renin inhibitor | |||
| 0.201 | 0.1 | 0.369 | Platelet antagonist | 0.369 0.034 DBMET00509 | DBMET00509 | |
| 0.118 | 0.017 | 0.238 | Na+ K+ transporting ATPase inhibitor | 0.238 0.002 DBMET00509 | DBMET00509 | |
| 0.164 | 0.063 | 0.164 | Phospholipase A2 inhibitor | |||
| 0.105 | 0.006 | 0.105 | Sphingosine kinase 2 inhibitor | |||
| 0.107 | 0.008 | 0.107 | Glutamate (mGluR6) antagonist | |||
| 0.131 | 0.033 | 0.131 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.137 | 0.04 | 0.318 | Photosensitizer | 0.318 0.004 DBMET00509 | DBMET00509 | |
| 0.106 | 0.009 | 0.106 | Prostaglandin F2 alpha antagonist | |||
| 0.121 | 0.025 | 0.121 | Ornithine decarboxylase inhibitor | |||
| 0.146 | 0.05 | 0.146 | Nav1.3 sodium channel blocker | |||
| 0.1 | 0.005 | 0.1 | Sphingosine 1-phosphate receptor agonist | |||
| 0.147 | 0.052 | 0.147 | Heat shock protein 70 antagonist | 0.135 0.094 DBMET00509 | ||
| 0.155 | 0.06 | 0.155 | MAP kinase 3 inhibitor | |||
| 0.149 | 0.055 | 0.149 | Nav1.6 sodium channel blocker | |||
| 0.108 | 0.014 | 0.108 | Purinergic P2X1 antagonist | 0.058 0.047 DBMET00509 | ||
| 0.204 | 0.112 | 0.204 | Neuropeptide Y2 antagonist | |||
| 0.115 | 0.023 | 0.134 | ATPase (Vacuolar H+) inhibitor | 0.134 0.012 DBMET00509 | DBMET00509 | |
| 0.103 | 0.011 | 0.292 | Interferon inducer | 0.292 0.002 DBMET00509 | DBMET00509 | |
| 0.15 | 0.06 | 0.15 | MAP3K9 inhibitor | |||
| 0.093 | 0.005 | 0.093 | Sphingosine 1-phosphate receptor 1 agonist | |||
| 0.111 | 0.023 | 0.111 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.098 | 0.01 | 0.098 | Exportin-1 inhibitor | |||
| 0.094 | 0.006 | 0.098 | Adenosine deaminase inhibitor | 0.098 0.006 DBMET00509 | DBMET00509 | |
| 0.103 | 0.015 | 0.103 | Vanilloid 4 agonist | |||
| 0.113 | 0.027 | 0.113 | Glutathione S-transferase inhibitor | |||
| 0.101 | 0.014 | 0.101 | Beta 3 adrenoreceptor antagonist | |||
| 0.129 | 0.043 | 0.129 | Sphingosine 1-phosphate receptor 2 agonist | |||
| 0.088 | 0.003 | 0.088 | Prostaglandin EP2 agonist | |||
| 0.103 | 0.019 | 0.103 | Ribonucleoside-diphosphate reductase inhibitor | |||
| 0.104 | 0.02 | 0.104 | Ribonucleotide reductase inhibitor | |||
| 0.098 | 0.014 | 0.098 | MAP kinase kinase 7 inhibitor | |||
| 0.189 | 0.106 | 0.817 | Free radical scavenger | 0.817 0.004 DBMET00509 | DBMET00509 | |
| 0.086 | 0.005 | 0.086 | Sphingosine kinase 1 inhibitor | |||
| 0.092 | 0.01 | 0.092 | MDM2 inhibitor | |||
| 0.09 | 0.009 | 0.09 | Calcium channel P-type blocker | |||
| 0.144 | 0.064 | 0.144 | Bone formation stimulant | |||
| 0.152 | 0.072 | 0.182 | CF transmembrane conductance regulator agonist | 0.182 0.034 DBMET00509 | DBMET00509 | |
| 0.087 | 0.007 | 0.087 | Lysophosphatidic acid 3 receptor antagonist | |||
| 0.097 | 0.018 | 0.097 | Beta adrenoreceptor antagonist | |||
| 0.082 | 0.003 | 0.098 | Uridine phosphorylase inhibitor | 0.098 0.002 DBMET00509 | DBMET00509 | |
| 0.103 | 0.025 | 0.103 | GABA aminotransferase inhibitor | 0.092 0.033 DBMET00509 | ||
| 0.12 | 0.043 | 0.368 | Toll-Like receptor 4 antagonist | 0.368 0.003 DBMET00509 | DBMET00509 | |
| 0.122 | 0.045 | 0.122 | Carbonic anhydrase XV inhibitor | |||
| 0.094 | 0.018 | 0.094 | Phospholipase D inhibitor | |||
| 0.119 | 0.045 | 0.125 | Carbonic anhydrase III inhibitor | 0.125 0.041 DBMET00509 | DBMET00509 | |
| 0.078 | 0.004 | 0.078 | Prostaglandin E2 agonist | |||
| 0.095 | 0.021 | 0.095 | Secretase beta inhibitor | |||
| 0.086 | 0.014 | 0.086 | Beta 1 adrenoreceptor antagonist | |||
| 0.159 | 0.087 | 0.159 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.105 | 0.034 | 0.105 | Adrenaline agonist | |||
| 0.074 | 0.004 | 0.074 | Guanylate cyclase inhibitor | 0.072 0.004 DBMET00509 | ||
| 0.075 | 0.005 | 0.075 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.049 0.009 DBMET00509 | ||
| 0.101 | 0.032 | 0.101 | mTOR complex 2 inhibitor | |||
| 0.091 | 0.022 | 0.091 | Prostaglandin EP2 antagonist | |||
| 0.104 | 0.039 | 0.104 | ALK inhibitor | |||
| 0.074 | 0.01 | 0.074 | Adenylate cyclase 1 inhibitor | |||
| 0.073 | 0.01 | 0.252 | Heparanase inhibitor | 0.252 0.002 DBMET00509 | DBMET00509 | |
| 0.123 | 0.06 | 0.4 | Monophenol monooxygenase inhibitor | 0.4 0.011 DBMET00509 | DBMET00509 | |
| 0.133 | 0.07 | 0.133 | Nav1.2 sodium channel blocker | |||
| 0.073 | 0.01 | 0.081 | Thymidine kinase inhibitor | 0.081 0.008 DBMET00509 | DBMET00509 | |
| 0.117 | 0.055 | 0.117 | Protein kinase C gamma inhibitor | |||
| 0.069 | 0.007 | 0.069 | GABA uptake inhibitor | |||
| 0.099 | 0.038 | 0.107 | Carbonic anhydrase XIII inhibitor | 0.107 0.034 DBMET00509 | DBMET00509 | |
| 0.165 | 0.104 | 0.165 | Psychostimulant | |||
| 0.071 | 0.01 | 0.071 | Immunoglobulin Fc receptor antagonist | |||
| 0.116 | 0.056 | 0.116 | Falcipain 3 inhibitor | |||
| 0.067 | 0.009 | 0.067 | Dopamine beta hydroxylase inhibitor | |||
| 0.072 | 0.015 | 0.072 | Beta 2 adrenoreceptor antagonist | |||
| 0.059 | 0.003 | 0.059 | Lysophosphatidic acid receptor 1 agonist | |||
| 0.073 | 0.018 | 0.073 | Diacylglycerol O-acyltransferase inhibitor | |||
| 0.212 | 0.157 | 0.807 | Transcription factor NF kappa B inhibitor | 0.807 0.012 DBMET00509 | DBMET00509 | |
| 0.064 | 0.01 | 0.064 | Microtubule stabilization | 0.052 0.025 DBMET00509 | ||
| 0.093 | 0.04 | 0.093 | D-Ala-D-Ala ligase inhibitor | |||
| 0.056 | 0.003 | 0.056 | Ileal bile acid transport inhibitor | 0.032 0.005 DBMET00509 | ||
| 0.144 | 0.092 | 0.144 | Growth hormone agonist | |||
| 0.053 | 0.002 | 0.053 | Lysophosphatidic acid receptor 3 agonist | |||
| 0.068 | 0.017 | 0.068 | Pregnane X receptor antagonist | |||
| 0.091 | 0.042 | 0.253 | Glycine receptor antagonist | 0.253 0.003 DBMET00509 | DBMET00509 | |
| 0.065 | 0.016 | 0.065 | Squalene epoxidase inhibitor | 0.056 0.025 DBMET00509 | ||
| 0.054 | 0.005 | 0.054 | Methionyl aminopeptidase 1 inhibitor | |||
| 0.053 | 0.006 | 0.053 | HMG CoA reductase inhibitor | |||
| 0.052 | 0.004 | 0.052 | Prostaglandin F2 alpha agonist | |||
| 0.053 | 0.006 | 0.213 | Sodium/glucose cotransporter 2 inhibitor | 0.213 0.001 DBMET00509 | DBMET00509 | |
| 0.056 | 0.009 | 0.056 | Glutamate (mGluR8) agonist | |||
| 0.052 | 0.006 | 0.052 | Methionyl aminopeptidase 2 inhibitor | |||
| 0.077 | 0.031 | 0.077 | Glutamate (mGluR7) antagonist | |||
| 0.076 | 0.031 | 0.076 | NMDA receptor glycine site agonist | |||
| 0.191 | 0.147 | 0.25 | Transcription factor STAT3 inhibitor | 0.25 0.083 DBMET00509 | DBMET00509 | |
| 0.07 | 0.026 | 0.07 | Sphingosine 1-phosphate receptor 3 antagonist | |||
| 0.055 | 0.01 | 0.055 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.068 | 0.023 | 0.068 | Beta 2 adrenoreceptor agonist | |||
| 0.056 | 0.012 | 0.056 | Membrane dipeptidase inhibitor | |||
| 0.133 | 0.089 | 0.133 | Cytidine deaminase inhibitor | |||
| 0.078 | 0.033 | 0.078 | Neutrophil collagenase inhibitor | |||
| 0.058 | 0.015 | 0.208 | Cytokine production stimulant | 0.208 0.002 DBMET00509 | DBMET00509 | |
| 0.052 | 0.008 | 0.052 | Lysophosphatidic acid 2 receptor antagonist | |||
| 0.053 | 0.011 | 0.053 | Kainate receptor agonist | |||
| 0.094 | 0.052 | 0.094 | Aminoacyl-tRNA synthetase inhibitor | |||
| 0.067 | 0.026 | 0.313 | Protein 50S ribosomal subunit inhibitor | 0.313 0.003 DBMET00509 | DBMET00509 | |
| 0.053 | 0.013 | 0.068 | Arginase inhibitor | 0.068 0.008 DBMET00509 | DBMET00509 | |
| 0.103 | 0.063 | 0.103 | Nav1.1 sodium channel blocker | |||
| 0.088 | 0.048 | 0.088 | Carbonic anhydrase VI inhibitor | 0.085 0.052 DBMET00509 | ||
| 0.097 | 0.058 | 0.097 | Potassium channel (Ca-activated) activator | |||
| 0.108 | 0.069 | 0.108 | Acetylcholine release stimulant | |||
| 0.121 | 0.082 | 0.121 | Sodium channel blocker | |||
| 0.078 | 0.04 | 0.078 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.055 | 0.017 | 0.055 | Geranyltranstransferase inhibitor | |||
| 0.117 | 0.079 | 0.357 | DNA repair enzyme inhibitor | 0.357 0.004 DBMET00509 | DBMET00509 | |
| 0.042 | 0.005 | 0.042 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.032 0.009 DBMET00509 | ||
| 0.05 | 0.013 | 0.17 | Antibiotic Aminoglycoside-like | 0.17 0.001 DBMET00509 | DBMET00509 | |
| 0.05 | 0.014 | 0.05 | Heme oxygenase inhibitor | |||
| 0.111 | 0.075 | 0.111 | Interleukin 8 antagonist | |||
| 0.052 | 0.016 | 0.052 | Plasmepsin II inhibitor | |||
| 0.079 | 0.043 | 0.146 | Phosphodiesterase VI inhibitor | 0.146 0.007 DBMET00509 | DBMET00509 | |
| 0.042 | 0.006 | 0.3 | Sodium/glucose cotransporter inhibitor | 0.3 0.001 DBMET00509 | DBMET00509 | |
| 0.061 | 0.026 | 0.061 | Leukotriene C antagonist | |||
| 0.04 | 0.005 | 0.04 | Vitamin D receptor antagonist | |||
| 0.04 | 0.005 | 0.04 | Estrogen-related receptor gamma antagonist | |||
| 0.051 | 0.016 | 0.051 | Calcitonin receptor agonist | |||
| 0.044 | 0.009 | 0.044 | Lysine carboxypeptidase inhibitor | |||
| 0.091 | 0.057 | 0.091 | Phosphodiesterase I inhibitor | |||
| 0.046 | 0.012 | 0.046 | Vanilloid 3 antagonist | |||
| 0.037 | 0.003 | 0.037 | Neuraminidase (Influenza B) inhibitor | |||
| 0.074 | 0.04 | 0.074 | Protein kinase C beta inhibitor | 0.067 0.053 DBMET00509 | ||
| 0.073 | 0.039 | 0.073 | Glucagon-like peptide 1 agonist | |||
| 0.059 | 0.025 | 0.059 | Bombesin 2 receptor antagonist | |||
| 0.044 | 0.01 | 0.044 | Cholesterol ester transfer protein antagonist | |||
| 0.095 | 0.062 | 0.095 | Bile acid receptor antagonist | |||
| 0.064 | 0.031 | 0.064 | Carbonic anhydrase VB inhibitor | |||
| 0.043 | 0.011 | 0.043 | Prostaglandin D2 agonist | |||
| 0.068 | 0.037 | 0.068 | NMDA receptor agonist | |||
| 0.049 | 0.019 | 0.049 | Beta adrenoreceptor agonist | |||
| 0.04 | 0.01 | 0.04 | Glutamate (mGluR3) agonist | |||
| 0.036 | 0.006 | 0.036 | Hedgehog signaling activator | |||
| 0.054 | 0.024 | 0.054 | Aldosterone antagonist | |||
| 0.058 | 0.029 | 0.058 | Sphingosine 1-phosphate receptor 5 agonist | |||
| 0.038 | 0.008 | 0.038 | Purinergic P2Y15 antagonist | |||
| 0.063 | 0.035 | 0.063 | Heat shock protein 90 beta antagonist | |||
| 0.032 | 0.004 | 0.032 | Thymidine kinase (Herpes simplex virus 2) inhibitor | |||
| 0.099 | 0.071 | 0.463 | Topoisomerase I inhibitor | 0.463 0.004 DBMET00509 | DBMET00509 | |
| 0.069 | 0.041 | 0.069 | Leukotriene antagonist | |||
| 0.059 | 0.031 | 0.059 | Dihydroorotate oxidase inhibitor | |||
| 0.042 | 0.014 | 0.065 | Ceramide glucosyltransferase inhibitor | 0.065 0.004 DBMET00509 | DBMET00509 | |
| 0.058 | 0.031 | 0.058 | Leukotriene B4 antagonist | |||
| 0.032 | 0.005 | 0.032 | Isoleucine-tRNA ligase inhibitor | |||
| 0.059 | 0.032 | 0.059 | Sphingosine 1-phosphate receptor 1 antagonist | |||
| 0.095 | 0.07 | 0.095 | Glutamate (mGluR7) agonist | |||
| 0.054 | 0.029 | 0.22 | Antimetabolite | 0.22 0.009 DBMET00509 | DBMET00509 | |
| 0.061 | 0.035 | 0.061 | Ryanodine receptor antagonist | |||
| 0.036 | 0.011 | 0.036 | Purinergic P2T antagonist | |||
| 0.029 | 0.004 | 0.029 | Thromboxane A2 agonist | |||
| 0.029 | 0.004 | 0.029 | Carbonic anhydrase X inhibitor | |||
| 0.029 | 0.004 | 0.029 | Carbonic anhydrase VIII inhibitor | |||
| 0.039 | 0.014 | 0.039 | ATP citrate lysase inhibitor | |||
| 0.062 | 0.038 | 0.062 | Cathepsin E inhibitor | |||
| 0.042 | 0.019 | 0.042 | VCAM-1 antagonist | |||
| 0.037 | 0.014 | 0.037 | Estrogen-related receptor beta antagonist | |||
| 0.027 | 0.003 | 0.027 | Methylmalonyl-CoA mutase inhibitor | |||
| 0.042 | 0.019 | 0.042 | VCAM antagonist | |||
| 0.042 | 0.019 | 0.042 | Glutamate (mGluR3) antagonist | |||
| 0.065 | 0.043 | 0.065 | Protease 3C (Human rhinovirus) inhibitor | |||
| 0.097 | 0.075 | 0.422 | AMP-activated protein kinase stimulant | 0.422 0.004 DBMET00509 | DBMET00509 | |
| 0.026 | 0.004 | 0.056 | Antibiotic Anthracycline-like | 0.056 0.001 DBMET00509 | DBMET00509 | |
| 0.032 | 0.01 | 0.032 | Thymidine phosphorylase inhibitor | 0.027 0.016 DBMET00509 | ||
| 0.128 | 0.106 | 0.128 | Pregnane X receptor agonist | |||
| 0.142 | 0.122 | 0.142 | Neurotensin receptor agonist | |||
| 0.067 | 0.047 | 0.067 | Acetylcholine M5 receptor agonist | |||
| 0.103 | 0.083 | 0.103 | TRPA1 agonist | |||
| 0.024 | 0.005 | 0.024 | Vitamin D receptor agonist | |||
| 0.048 | 0.028 | 0.048 | Purinergic P2Y antagonist | |||
| 0.094 | 0.074 | 0.094 | Gastric antisecretory | |||
| 0.043 | 0.024 | 0.043 | Dopamine D5 agonist | |||
| 0.058 | 0.039 | 0.082 | Lipocortins synthesis agonist | 0.082 0.013 DBMET00509 | DBMET00509 | |
| 0.051 | 0.032 | 0.051 | Metalloproteinase-3 inhibitor | |||
| 0.031 | 0.012 | 0.031 | Calcium-sensing receptor agonist | |||
| 0.023 | 0.005 | 0.066 | Telomerase stimulant | 0.066 0.001 DBMET00509 | DBMET00509 | |
| 0.025 | 0.007 | 0.025 | Calcium-sensing receptor antagonist | |||
| 0.021 | 0.003 | 0.021 | Purine nucleoside phosphorylase inhibitor | |||
| 0.041 | 0.024 | 0.041 | Vascular adhesion protein 1 inhibitor | |||
| 0.048 | 0.031 | 0.048 | Thymidylate synthase inhibitor | |||
| 0.103 | 0.086 | 0.103 | Caspase 3 inhibitor | |||
| 0.031 | 0.015 | 0.031 | MAP3K8 inhibitor | |||
| 0.036 | 0.02 | 0.036 | Sirtuin 2 inhibitor | |||
| 0.081 | 0.065 | 0.081 | NMDA receptor antagonist | |||
| 0.028 | 0.013 | 0.071 | Vanilloid 2 agonist | 0.071 0.002 DBMET00509 | DBMET00509 | |
| 0.018 | 0.004 | 0.018 | Thromboxane agonist | |||
| 0.022 | 0.007 | 0.022 | Adenosine A2 receptor agonist | |||
| 0.039 | 0.026 | 0.039 | Leukotriene C4 antagonist | |||
| 0.054 | 0.04 | 0.054 | Neuropeptide agonist | |||
| 0.061 | 0.047 | 0.097 | Nitric oxide donor | 0.097 0.01 DBMET00509 | DBMET00509 | |
| 0.035 | 0.022 | 0.035 | RNA-directed RNA polymerase inhibitor | |||
| 0.057 | 0.045 | 0.057 | Androgen agonist | |||
| 0.09 | 0.077 | 0.09 | Insulin receptor antagonist | |||
| 0.042 | 0.03 | 0.042 | GABA B receptor antagonist | |||
| 0.086 | 0.074 | 0.086 | Protein kinase C zeta inhibitor | |||
| 0.026 | 0.014 | 0.026 | Glutamate (mGluR1) agonist | |||
| 0.035 | 0.023 | 0.035 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | |||
| 0.02 | 0.009 | 0.02 | Prostacyclin agonist | |||
| 0.024 | 0.013 | 0.024 | ICAM 1 antagonist | |||
| 0.018 | 0.008 | 0.018 | Purinergic P2Y1 agonist | 0.015 0.011 DBMET00509 | ||
| 0.073 | 0.063 | 0.073 | Sphingosine 1-phosphate receptor antagonist | |||
| 0.114 | 0.104 | 0.265 | Neurotrophic factor | 0.265 0.01 DBMET00509 | DBMET00509 | |
| 0.02 | 0.01 | 0.02 | Cyclin T1 inhibitor | |||
| 0.019 | 0.009 | 0.019 | Prostaglandin EP4 agonist | |||
| 0.061 | 0.051 | 0.061 | Aryl hydrocarbon receptor antagonist | |||
| 0.018 | 0.009 | 0.018 | Adenosine A2a receptor agonist | |||
| 0.071 | 0.061 | 0.071 | Potassium channel (Tandem pore domain) blocker | |||
| 0.079 | 0.071 | 0.364 | Transcription factor NF kappa B stimulant | 0.364 0.003 DBMET00509 | DBMET00509 | |
| 0.027 | 0.02 | 0.027 | LFA antagonist | |||
| 0.023 | 0.015 | 0.023 | Glutamate (mGluR1a) agonist | |||
| 0.023 | 0.016 | 0.023 | Beta 1 adrenoreceptor agonist | |||
| 0.014 | 0.007 | 0.014 | Glutamate (mGluR6) agonist | |||
| 0.02 | 0.015 | 0.02 | Retinoid X beta receptor antagonist | |||
| 0.054 | 0.048 | 0.054 | Cyclin-dependent kinase 6 inhibitor | |||
| 0.053 | 0.048 | 0.059 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.059 0.04 DBMET00509 | DBMET00509 | |
| 0.038 | 0.034 | 0.038 | Oxytocin agonist | |||
| 0.041 | 0.037 | 0.041 | AICAR transformylase inhibitor | |||
| 0.062 | 0.057 | 0.062 | Carbonic anhydrase VA inhibitor | |||
| 0.022 | 0.018 | 0.022 | Aminopeptidase P inhibitor | |||
| 0.045 | 0.041 | 0.045 | Topoisomerase II beta inhibitor | |||
| 0.037 | 0.034 | 0.037 | Neurokinin 2 antagonist | |||
| 0.031 | 0.028 | 0.031 | Protein kinase (CK2) beta inhibitor | |||
| 0.014 | 0.011 | 0.014 | S-adenosyl-L-homocysteine hydrolase inhibitor | |||
| 0.035 | 0.032 | 0.035 | Retinoid X receptor antagonist | |||
| 0.032 | 0.029 | 0.032 | Retinoid X alpha receptor antagonist | |||
| 0.034 | 0.031 | 0.034 | Tryptophan 5 hydroxylase inhibitor | |||
| 0.084 | 0.082 | 0.408 | Xanthine oxidase inhibitor | 0.408 0.004 DBMET00509 | DBMET00509 | |
| 0.031 | 0.029 | 0.031 | Retinoid X receptor agonist | |||
| 0.01 | 0.008 | 0.018 | Purinergic P2Y2 agonist | 0.018 0.002 DBMET00509 | DBMET00509 | |
| 0.033 | 0.032 | 0.033 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | |||
| 0.036 | 0.035 | 0.036 | Glutamate (mGluR1a) antagonist | |||
| 0.021 | 0.02 | 0.021 | Retinoic acid gamma receptor agonist | |||
| 0.033 | 0.032 | 0.033 | Farnesoid X receptor agonist | |||
| 0.018 | 0.017 | 0.018 | Hexokinase stimulant | |||
| 0.001 | 0.005 | 0.003 | Purinergic P2Y6 agonist | 0.003 0.002 DBMET00509 | DBMET00509 | |
| 0.088 | 0.093 | 0.36 | Beta glucuronidase inhibitor | 0.36 0.005 DBMET00509 | DBMET00509 | |
| 0.172 | 0.183 | 0.244 | Transcription factor STAT inhibitor | 0.244 0.091 DBMET00509 | DBMET00509 | |
| 0.186 | 0.2 | 0.772 | Apoptosis antagonist | 0.772 0.004 DBMET00509 | DBMET00509 | |
| 0.038 | 0.053 | 0.153 | Carbonic anhydrase XIV inhibitor | 0.153 0.005 DBMET00509 | DBMET00509 | |
| 0.015 | 0.032 | 0.04 | Adenosine A1 receptor agonist | 0.04 0.007 DBMET00509 | DBMET00509 | |
| 0.014 | 0.032 | 0.02 | Corticosteroid-like | 0.02 0.016 DBMET00509 | DBMET00509 | |
| 0.016 | 0.037 | 0.127 | Protein 30S ribosomal subunit inhibitor | 0.127 0.002 DBMET00509 | DBMET00509 | |
| 0.005 | 0.036 | 0.016 | Purinergic P2Y agonist | 0.016 0.006 DBMET00509 | DBMET00509 | |
| 0.004 | 0.037 | 0.021 | Purinergic P2 agonist | 0.021 0.006 DBMET00509 | DBMET00509 | |
| 0.004 | 0.037 | 0.021 | Purinergic receptor agonist | 0.021 0.006 DBMET00509 | DBMET00509 | |
| 0.095 | 0.128 | 0.296 | Interleukin 4 antagonist | 0.296 0.009 DBMET00509 | DBMET00509 | |
| 0.019 | 0.061 | 0.041 | 1,3-Beta-glucan synthase inhibitor | 0.041 0.004 DBMET00509 | DBMET00509 | |
| 0.131 | 0.173 | 0.465 | Antiamyloidogenic | 0.465 0.019 DBMET00509 | DBMET00509 | |
| 0.036 | 0.078 | 0.118 | Factor IXa inhibitor | 0.118 0.006 DBMET00509 | DBMET00509 | |
| 0.079 | 0.123 | 0.318 | Beta amyloid protein antagonist | 0.318 0.005 DBMET00509 | DBMET00509 | |
| 0.011 | 0.056 | 0.023 | Purinergic P2X agonist | 0.023 0.022 DBMET00509 | DBMET00509 | |
| 0.212 | 0.257 | 0.862 | Apoptosis agonist | 0.862 0.009 DBMET00509 | DBMET00509 | |
| 0.032 | 0.083 | 0.048 | Cholesterol esterase inhibitor | 0.048 0.033 DBMET00509 | DBMET00509 | |
| 0.019 | 0.072 | 0.132 | Toll-Like receptor 4 agonist | 0.132 0.002 DBMET00509 | DBMET00509 | |
| 0.043 | 0.098 | 0.132 | Adenine nucleotide translocase inhibitor | 0.132 0.003 DBMET00509 | DBMET00509 | |
| 0.002 | 0.057 | 0.082 | Antibiotic Macrolide-like | 0.082 0.003 DBMET00509 | DBMET00509 | |
| 0.086 | 0.151 | 0.455 | Thrombolytic | 0.455 0.007 DBMET00509 | DBMET00509 | |
| 0.051 | 0.116 | 0.082 | Adenosine A3 receptor antagonist | 0.082 0.04 DBMET00509 | DBMET00509 | |
| 0.044 | 0.115 | 0.241 | Topoisomerase II alpha inhibitor | 0.241 0.011 DBMET00509 | DBMET00509 | |
| 0.116 | 0.208 | 0.778 | Tumour necrosis factor alpha release inhibitor | 0.778 0.004 DBMET00509 | DBMET00509 | |
| 0.011 | 0.109 | 0.037 | Caspase 2 inhibitor | 0.037 0.017 DBMET00509 | DBMET00509 | |
| 0.015 | 0.123 | 0.075 | Carbonic anhydrase II inhibitor | 0.075 0.027 DBMET00509 | DBMET00509 | |
| 0.072 | 0.187 | 0.136 | Toll-Like receptor antagonist | 0.136 0.066 DBMET00509 | DBMET00509 | |
| 0.018 | 0.135 | 0.09 | Carbonic anhydrase inhibitor | 0.09 0.03 DBMET00509 | DBMET00509 | |
| 0.014 | 0.134 | 0.067 | Carbonic anhydrase I inhibitor | 0.067 0.03 DBMET00509 | DBMET00509 | |
| 0.008 | 0.149 | 0.137 | Carbonic anhydrase IX inhibitor | 0.137 0.014 DBMET00509 | DBMET00509 | |
| 0.008 | 0.152 | 0.149 | Carbonic anhydrase XII inhibitor | 0.149 0.013 DBMET00509 | DBMET00509 | |
| 0.014 | 0.19 | 0.132 | Aldose reductase inhibitor | 0.132 0.013 DBMET00509 | DBMET00509 | |
| 0.005 | 0.221 | 0.023 | Inosine monophosphate dehydrogenase 1 inhibitor | 0.023 0.012 DBMET00509 | DBMET00509 | |
| 0.126 | 0.351 | 0.761 | Caspase 3 stimulant | 0.761 0.005 DBMET00509 | DBMET00509 | |
| 0.037 | 0.279 | 0.142 | Cell adhesion molecule inhibitor | 0.142 0.017 DBMET00509 | DBMET00509 | |
| 0.049 | 0.297 | 0.48 | Cell adhesion inhibitor | 0.48 0.004 DBMET00509 | DBMET00509 | |
| 0.026 | 0.276 | 0.048 | Factor III inhibitor | 0.048 0.04 DBMET00509 | DBMET00509 | |
| 0.034 | 0.292 | 0.192 | Uric acid excretion stimulant | 0.192 0.014 DBMET00509 | DBMET00509 | |
| 0.035 | 0.33 | 0.545 | Lipid peroxidase inhibitor | 0.545 0.005 DBMET00509 | DBMET00509 | |
| 0.005 | 0.314 | 0.016 | Adenosine A3 receptor agonist | 0.016 0.014 DBMET00509 | DBMET00509 | |
| 0.045 | 0.398 | 0.154 | Interleukin 12 antagonist | 0.154 0.011 DBMET00509 | DBMET00509 | |
| 0.021 | 0.397 | 0.441 | Topoisomerase II inhibitor | 0.441 0.008 DBMET00509 | DBMET00509 | |
| 0.027 | 0.464 | 0.33 | Anticoagulant | 0.33 0.024 DBMET00509 | DBMET00509 | |
| 0.034 | 0.519 | 0.539 | Platelet adhesion inhibitor | 0.539 0.005 DBMET00509 | DBMET00509 | |
| 0.004 | 0.516 | 0.085 | Motilin receptor agonist | 0.085 0.005 DBMET00509 | DBMET00509 | |
| 0.004 | 0.57 | 0.02 | O6-alkylguanine-DNA alkyltransferase inhibitor | 0.02 0.007 DBMET00509 | DBMET00509 | |
| 0.012 | 0.585 | 0.084 | Glucose-6-phosphate translocase inhibitor | 0.084 0.01 DBMET00509 | DBMET00509 | |
| 0.037 | 0.625 | 0.744 | NOS3 expression enhancer | 0.744 0.003 DBMET00509 | DBMET00509 | |
| 0.009 | 0.745 | 0.203 | DNA intercalator | 0.203 0.025 DBMET00509 | DBMET00509 | |
| 0.013 | 0.782 | 0.142 | Amyloid beta aggregation inhibitor | 0.142 0.114 DBMET00509 | DBMET00509 | |
| 0.005 | 0.813 | 0.121 | Lipase inhibitor | 0.121 0.018 DBMET00509 | DBMET00509 | |
| 0.005 | 0.869 | 0.112 | Cyclooxygenase 1 inhibitor | 0.112 0.088 DBMET00509 | DBMET00509 | |
| 0.039 | 0.963 | 0.14 | CC chemokine 6 receptor antagonist | 0.14 0.041 DBMET00509 | DBMET00509 | |
| 0.003 | 0.942 | 0.098 | EphA2 antagonist | 0.098 0.078 DBMET00509 | DBMET00509 | |
| 0.005 | 0.947 | 0.558 | Angiogenesis inhibitor | 0.558 0.021 DBMET00509 | DBMET00509 | |
| 0.007 | 0.976 | 0.24 | Thioredoxin inhibitor | 0.24 0.005 DBMET00509 | DBMET00509 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |